Explore the BCG's Bladder Cancer-Fighting Mechanisms

New research using a novel zebrafish model has uncovered immune mechanisms behind BCG.

Novel zebrafish model has helped researchers discover the immune mechanisms that make Bacillus Calmette-Guerin (BCG) effective against bladder cancer ().

The zebrafish Avatars (zAvatars) are an experimental model where tumor cells from a cancer patient are injected into zebrafish embryos, allowing the tumors to grow inside them.

BCG Vaccine Prevents COVID-19
The connection of BCG vaccine with decreased and less severe course COVID-19 is proven to attenuate the disease.

‘Did You Know?
Bladder cancer is the 10th most common cancer worldwide, with approximately 573,000 new cases annually. #cancer #bcg #bladdercancer’

This model provides a fast and personalized method to test cancer treatments, delivering results in days rather than the weeks or months required with traditional mouse models. The research was led by Mayra Martinez-Lopez, of the Champalimaud Foundation.

Immune Responses in Bladder Cancer Therapy

Martinez-Lopez had a personal, vaunted ambition in this research. She was inspired to explore the BCG vaccine's role in cancer after recalling her childhood vaccination against tuberculosis in South America, which has been a persistent health challenge in the country.

The BCG vaccine, originally developed against tuberculosis in the 1920s, has been used as a cancer immunotherapy since the 1970s.

BCG Vaccine may Help Elderly Fight Coronavirus: ICMR Study
Bacille Calmette-Guerin (BCG) vaccine can help fight against COVID-19 in the elderly. BCG vaccination induces enhanced innate and adaptive immunity in elderly individuals which may prove beneficial against the coronavirus.

Despite its empirical use, BCG remains a gold-standard treatment for early-stage bladder cancer, offering a 15-year survival rate of 60 percent to 70 percent.

However, 30 percent to 50 percent of cases are unresponsive to the treatment, often necessitating bladder removal.

The BCG Vaccine and COVID-19: Seeking Answers in the BRACE Trial
BCG vaccine, administered to millions of infants globally each year to prevent tuberculosis, is being investigated for its potential to protect against COVID-19.

The team discovered that macrophages are heavily recruited to the tumor site after BCG injection in the zAvatars.

Using light sheet microscopy and confocal imaging, they observed macrophages directly killing human bladder cancer cells via apoptosis, triggered by a substance called tumor necrosis factor (TNF) secreted by the macrophages.

Tuberculosis
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to other organs.

When macrophages were depleted, the anti-tumor effects of BCG were completely blocked, highlighting their essential role in the immune response.

“This study not only unravels the mechanisms of BCG’s anti-tumor action but also demonstrates the potential of the zebrafish Avatar model as a powerful tool for drug discovery in oncology,” Martinez-Lopez concluded.

Reference:

Scientists unravel how the BCG vaccine leads to the destruction of bladder cancer cells - (https://www.fchampalimaud.org/news/scientists-unravel-how-bcg-vaccine-leads-destruction-bladder-cancer-cells)

Source-IANS